Product NDC: | 0078-0053 |
Proprietary Name: | Methergine |
Non Proprietary Name: | methylergonovine maleate |
Active Ingredient(s): | .2 mg/mL & nbsp; methylergonovine maleate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0053 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA006035 |
Marketing Category: | NDA |
Start Marketing Date: | 20020128 |
Package NDC: | 0078-0053-03 |
Package Description: | 20 AMPULE in 1 BOX (0078-0053-03) > 1 mL in 1 AMPULE (0078-0053-61) |
NDC Code | 0078-0053-03 |
Proprietary Name | Methergine |
Package Description | 20 AMPULE in 1 BOX (0078-0053-03) > 1 mL in 1 AMPULE (0078-0053-61) |
Product NDC | 0078-0053 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylergonovine maleate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20020128 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | METHYLERGONOVINE MALEATE |
Strength Number | .2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |